Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ketoconazole and the antifungals.

J L Parkin

    Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
    |February 1, 1985
    PubMed
    Summary

    Ketoconazole is a new oral antifungal effective for mucocutaneous candidiasis, showing a 97% response rate. While generally safe for outpatients, potential hepatitis and infection relapse require monitoring.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Overlapping thin-section fast spin-echo MR of the large vestibular aqueduct syndrome.

    AJNR. American journal of neuroradiology·1997
    Same author

    Ineraid multichannel cochlear implant.

    Advances in oto-rhino-laryngology·1997
    Same author

    Percutaneous pedestal in cochlear implantation.

    Advances in oto-rhino-laryngology·1997
    Same author

    Osseointegration and growth effects of temporal bone percutaneous pedestals.

    The American journal of otology·1996
    Same author

    Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhanced conventional spin-echo MR?

    AJNR. American journal of neuroradiology·1996
    Same author

    Cerebellopontine angle glioneuronal hamartoma.

    Surgical neurology·1996

    Area of Science:

    • Mycology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Fungal infections, particularly mucocutaneous candidiasis, pose treatment challenges.
    • Existing antifungal therapies have limitations in efficacy and safety profiles.
    • The introduction of novel antifungal agents is crucial for improving patient outcomes.

    Purpose of the Study:

    • To evaluate the efficacy and safety of ketoconazole for treating fungal infections.
    • To assess the response rate of ketoconazole in mucocutaneous candidiasis.
    • To compare ketoconazole with other available antifungal agents.

    Main Methods:

    • A review of ketoconazole's effectiveness in treating mucocutaneous candidiasis.
    • Analysis of reported positive response rates and toxicity profiles.
    • Case reporting of favorable responses in patients with post-irradiation candidiasis.

    Main Results:

    • Ketoconazole demonstrated a high positive response rate of 97% in mucocutaneous candidiasis.
    • Oral administration in outpatients showed a low risk of toxicity.
    • Favorable responses were observed in five patients with candidiasis post-irradiation therapy.

    Conclusions:

    • Ketoconazole is an effective new antifungal agent for mucocutaneous candidiasis.
    • The drug offers a viable oral treatment option for outpatients.
    • Hepatitis and infection relapse are potential complications that warrant consideration.

    Related Experiment Videos